About

J. Royden Ward has been chief analyst of the Cabot Benjamin Graham Value Investor since 2003. The advisory features the Cabot Value Model of low-risk and very-low-risk investments and the Cabot Enterprising Model of medium-risk investments and is directed to individual investors seeking a guide to profitable value investing. He has spent his entire career seeking strong investment returns for his clients. In 1969, Mr. Ward developed a computerized model based on formulas for a unique ranking system created by investment legend Benjamin Graham. Since then, he has directed all facets of the investment divisions for several financial planning/investment advisor organizations. Mr. Ward has successfully managed and monitored the performance of 300 individual accounts for conservative and aggressive investors using stocks, bonds, and mutual funds.

Content from Roy Ward

Blackstone Group: Alternative Assets
Roy Ward

Blackstone Group LP (BX) offers alternative asset management; it raises capital for, invests in and manages various investment...

Tickers: BX
Top Picks 2017: Chicago Bridge & Iron
Roy Ward

My Top Pick for 2017 for growth investors is an engineering company that was founded in 1889 and is headquartered in The Hague,...

Tickers: FB
Top Picks 2017: Facebook
Roy Ward

My Top Pick for 2017 is the world's largest social media company, suggests value investing specialist J. Royden Ward, editor of...

Tickers: FB
Celgene: Fast Growth and Value
Roy Ward

This featured recommendation - which concentrates on various cancers - is among the fastest growing companies in the biotech se...

Tickers: CELG
Value Expert Eyes Schwab
Roy Ward

My latest recommendation is an undervalued stock pick in the financial sector that should benefit from our new President, sugge...

Tickers: SCHW
Rising Rates: A Bonus for Schwab
Roy Ward

Our latest value stock recommendation is one of the largest brokerage firms in the U.S., primarily serving retail clients, note...

Tickers: SCHW
Biogen: Biotech Bet on MS and Alzheimer's
Roy Ward

Our latest featured stock is a biopharmaceutical company which delivers therapies for the treatment of neurodegenerative diseas...

Tickers: BIIB
Ulta Salon: Beauty Buy
Roy Ward

Our latest featured value recommendation is the largest beauty retailer in the US; the company provides one-stop shopping for 2...

Tickers: ULTA